The cost-effectiveness of initiating ranibizumab therapy in eyes with neovascular AMD with good vision: an economic model using real-world outcomes
Thomas Butt(University College London), Adnan Tufail(Moorfields Eye Hospital), Aaron Lee(Imperial College London), Cecilia S. Lee(University of Washington)
Cited by 23
Related Papers
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension
|Nature Medicine|2020|1.2k
Deep Learning Is Effective for Classifying Normal versus Age-Related Macular Degeneration OCT Images
|Ophthalmology Retina|2017|669
Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension
|Nature Medicine|2020|665
Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI
|Nature Medicine|2022|636
Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension
|The Lancet Digital Health|2020|453